Drug Profile
Alpha-1-antitrypsin inhalation - Grifols
Alternative Names: Alpha-1 HC; Alpha-1 HC aerosol; VR 179Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Bayer
- Developer Grifols; Vectura
- Class Acute-phase proteins; Alpha globulins; Anti-inflammatories; Antiallergics; Antihyperglycaemics; Blood proteins; Secretory proteinase inhibitory proteins; Serpins
- Mechanism of Action Serine endopeptidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cystic fibrosis
Most Recent Events
- 27 Aug 2019 Discontinued - Phase-II for Cystic fibrosis in USA (Inhalation) (Grifols pipeline, August 2019)
- 31 Jul 2015 Phase-II development is ongoing in Cystic fibrosis in USA (inhalation)
- 13 Mar 2014 Activaero GmbH has been acquired by Vectura